Free Trial
LON:IDH

Immunodiagnostic Systems (IDH) Share Price, News & Analysis

Immunodiagnostic Systems logo

About Immunodiagnostic Systems Stock (LON:IDH)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
378
378
52-Week Range
N/A
Volume
N/A
Average Volume
14,539 shs
Market Capitalization
£108.80 million
P/E Ratio
290.77
Dividend Yield
0.50%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Immunodiagnostic Systems Holdings PLC develops, manufactures, and sells in-vitro diagnostic tests to the clinical laboratory market in the United Kingdom, the United States, Germany, France, and internationally. It develops, manufactures, and markets immunoassays and automated immunoanalyser technologies to provide diagnostic outcomes for patients. It offers IDS-iSYS multi-discipline automated systems, which is based on chemiluminescence and absorbency technology is used for immunoassay testing. The company provides its products and services for diagnosis of bone metabolism, calcium metabolism, hypertension, chronic kidney disease mineral bone disorder, growth, fertility, autoimmunity, infectious disease, sarcoidosis, and allergy. Immunodiagnostic Systems Holdings PLC was founded in 1977 and is headquartered in Boldon, the United Kingdom.

Receive IDH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Immunodiagnostic Systems and its competitors with MarketBeat's FREE daily newsletter.

IDH Stock News Headlines

EQS-News: DATAGROUP Acquires ISC Innovative Systems Consulting AG
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
IDH.L Regulatory News
See More Headlines

IDH Stock Analysis - Frequently Asked Questions

Immunodiagnostic Systems Holdings PLC (LON:IDH) announced its quarterly earnings results on Wednesday, June, 20th. The company reported $5.70 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.60 by $3.10.

Shares of IDH stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Immunodiagnostic Systems investors own include Dechra Pharmaceuticals (DPH), iShares Biotechnology ETF (IBB), Redrow (RDW), Netflix (NFLX), Sysco (SYY), TP ICAP Group (TCAP) and Telford Homes (TEF).

Company Calendar

Last Earnings
6/20/2018
Today
5/04/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Medical Appliances & Equipment
Sub-Industry
N/A
Current Symbol
LON:IDH
CIK
N/A
Fax
N/A
Employees
147,000
Year Founded
N/A

Profitability

Trailing P/E Ratio
290.77
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£34.25 million
Price / Cash Flow
4.50
Book Value
GBX 187.60 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
£108.80 million
Optionable
Not Optionable
Beta
N/A
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (LON:IDH) was last updated on 5/4/2025 by MarketBeat.com Staff
From Our Partners